Compare CNTA & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTA | SOC |
|---|---|---|
| Founded | 2020 | 2020 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 648.0M |
| IPO Year | 2021 | N/A |
| Metric | CNTA | SOC |
|---|---|---|
| Price | $24.77 | $7.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $37.70 | $17.00 |
| AVG Volume (30 Days) | 1.5M | ★ 8.3M |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 118.88 | N/A |
| 52 Week Low | $9.60 | $3.72 |
| 52 Week High | $30.58 | $35.00 |
| Indicator | CNTA | SOC |
|---|---|---|
| Relative Strength Index (RSI) | 38.02 | 57.91 |
| Support Level | $25.59 | $5.04 |
| Resistance Level | $30.02 | $9.47 |
| Average True Range (ATR) | 1.29 | 0.74 |
| MACD | -0.67 | 0.58 |
| Stochastic Oscillator | 10.14 | 66.50 |
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.